TY - CHAP M1 - Book, Section TI - Mannosidosis A1 - Bissonnette, Bruno A1 - Luginbuehl, Igor A1 - Marciniak, Bruno A1 - Dalens, Bernard J. PY - 2006 T2 - Syndromes: Rapid Recognition and Perioperative Implications AB - Lysosomal glycoprotein storage disease with mental retardation, hearing loss, and recurrent infections (upper or lower respiratory tract, and gastrointestinal tract). Other clinical features include coarse face, prominent forehead, prominent jaw, diffuse dysfunction of the brain, severe ataxia, deafness, scoliosis, rheumatoid arthritis, hypotonia, and muscle pain. Two types are described: α and β. α-Mannosidosis displays clinical heterogeneity, ranging from very serious to very mild forms. β-Mannosidosis causes a severe disorder that affects the peripheral and central nervous systems. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/10/13 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=58075168 ER -